207 related articles for article (PubMed ID: 6374968)
41. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
42. A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.
Matsuda A; Kamata I; Iwamoto Y; Sakamoto Y; Kuzuya T
Diabetes Res Clin Pract; 1985 Oct; 1(3):161-7. PubMed ID: 3915262
[TBL] [Abstract][Full Text] [Related]
43. Assisting effects of lithium on hypoglycemic treatment in patients with diabetes.
Hu M; Wu H; Chao C
Biol Trace Elem Res; 1997; 60(1-2):131-7. PubMed ID: 9404682
[TBL] [Abstract][Full Text] [Related]
44. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
[TBL] [Abstract][Full Text] [Related]
45. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
[TBL] [Abstract][Full Text] [Related]
46. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
[TBL] [Abstract][Full Text] [Related]
47. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
[TBL] [Abstract][Full Text] [Related]
48. Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity.
Grajwer LA; Pildes RS; Horwitz DL; Rubenstein AH
J Pediatr; 1977 Jan; 90(1):42-8. PubMed ID: 830892
[TBL] [Abstract][Full Text] [Related]
49. Increasing serum osteocalcin after glycemic control in diabetic men.
Sayinalp S; Gedik O; Koray Z
Calcif Tissue Int; 1995 Dec; 57(6):422-5. PubMed ID: 8581873
[TBL] [Abstract][Full Text] [Related]
50. [Pancreatic B cell function and glucose intolerance in the elderly].
Nozaki T
Nihon Ika Daigaku Zasshi; 1989 Apr; 56(2):153-65. PubMed ID: 2659622
[TBL] [Abstract][Full Text] [Related]
51. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
52. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
[TBL] [Abstract][Full Text] [Related]
53. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
54. Changes in circulating adiponectin, leptin, glucose and C-peptide in patients with ketosis-prone diabetes.
Gupta P; Liu Y; Lapointe M; Yotsapon T; Sarat S; Cianflone K
Diabet Med; 2015 May; 32(5):692-700. PubMed ID: 25407468
[TBL] [Abstract][Full Text] [Related]
55. The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus.
Abdulkadir J; Mengesha B; Welde Gebriel Z; Keen H; Worku Y; Gebre P; Bekele A; Urga K; Taddesse AS
Diabetologia; 1990 Apr; 33(4):222-7. PubMed ID: 2112100
[TBL] [Abstract][Full Text] [Related]
56. A case of idiopathic type 1 diabetes with subsequent recovery of endogenous insulin secretion despite initial diagnosis of fulminant type 1 diabetes.
Kaneko K; Satake C; Yamamoto J; Takahashi H; Sawada S; Imai J; Yamada T; Katagiri H
Endocr J; 2017 Mar; 64(3):369-374. PubMed ID: 28070056
[TBL] [Abstract][Full Text] [Related]
57. Degradation and secretion of insulin in hepatic cirrhosis.
Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
[TBL] [Abstract][Full Text] [Related]
58. Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission.
Gosmanov AR; Smiley D; Robalino G; Siqueira JM; Peng L; Kitabchi AE; Umpierrez GE
Diabetes Care; 2010 Apr; 33(4):854-60. PubMed ID: 20067967
[TBL] [Abstract][Full Text] [Related]
59. Study of A- and B-cell function in beta-thalassemia major.
Maioli M; Pacifico A; Frulio T; Longinotti M
Acta Diabetol Lat; 1983; 20(2):143-52. PubMed ID: 6349202
[TBL] [Abstract][Full Text] [Related]
60. Appearance of type II diabetes mellitus in type I diabetic recipients of pancreas allografts.
Smith JL; Hunsicker LG; Yuh WT; Wright FH; Van Voorhis L; Corry RJ
Transplantation; 1989 Feb; 47(2):304-11. PubMed ID: 2465591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
